NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

manibiotech,

Costs change with availability of Flaskworks and demand for components which means that component supply chain for a significant amount of time/patients ought to be already worked out by now for all possible component needs which takes money. Declaring in advance for artisan vs Flaskworks differences should absolutely be made known as should Advent COGS/profitability vs that of NWBO. NWBO should receive and declare all revenue directly followed by distribution payments for manufacturing and digitization oversight services so nothing is hidden from investors as long as Linda is involved with both as separate entities during the commercial enterprise stage for both companies. Best wishes.